Early Detection and Interception of Cancer: Current Practice Recommendations and Novel Emerging Approaches
- Continuing Education
Elevate your approach to cancer prevention with this dynamic course offering practical guidance on current screening practices, management of high-risk populations, and the integration of emerging early detection technologies into clinical care.
- Live Online; In Person
Participants may attend either virtually or in person.
Continuing Education Credits
Earn up to:
5.00 AMA PRA Category 1 Credit(s) ™
5.00 ANCC contact hours
5.00 AAPA Category 1 CME Credits
View All
On This Page
Overview
Through this course we will provide a comprehensive review of current cancer screening guidelines, provide guidance regarding high-risk populations and their management, educate regarding emerging technologies for early cancer detection, and provide referral pathways for complex patients.
Learning Objectives
- Identify and implement current cancer screening guidelines, with a focus on early detection and intervention for high-risk populations, and provide recommendations for managing these patients.
- Identify and establish appropriate referral pathways for patients with pre-malignant conditions requiring specialized care.
- Evaluate emerging technologies in cancer detection and assess their application for early detection of cancer.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Dana-Farber Cancer Institute.
Participant Types
Specialty Physicians, Physician Assistants, Nurse Practitioners, Primary Care Physicians, and Genetic Counselors.
Schedule
All agenda sessions are in Eastern Time.
Monday, September 15, 2025
Welcome and Kick Off
Ben Ebert; Sapna Syngal; Betsy O'Donnell
9:05-9:10 am
Keynote: How To Counsel Your Patient About Alcohol and Cancer Risk
9:10-9:45 am
Management of DCIS (Ductal Carcinoma in Situ) and Other Breast Cancer Precursors
9:45-10:00 am
Precursors to Head and Neck, Oral Cancers, and Management
Glenn Hanna
10:00-10:15 am
Screening and Early Detection of Gynecologic Malignancies
Colleen Feltmate
10:15-10:30 am
Q&A
Colleen Feltmate; Glenn Hanna
10:30-10:45 am
Break
10:45-11:00 am
Screening and Early Detection of Dermatologic Malignancies
11:00-11:15 am
Unexplained Cytopenia - When to Consider Clonal hematopoiesis and myelodysplastic syndrome (MDS)
11:15-11:30 am
Intercepting Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma
11:30-11:45 am
Q&A
11:45 am-12:00 pm
Lunch Break
12:00-12:20 pm
Genetics 101: Identification and Genetic testing for inherited cancer predisposition
12:20-12:35 pm
Management of Hereditary Cancer Predisposition in Your Practice
12:35-12:50 pm
Management of IPMNs, Barrett's Esophagus and other Precursors to GI Cancer
Nicolette Rodriguez
12:50-1:05 pm
Screening and Early Detection of Lung Cancer
Jacob Sands
1:05-1:20 pm
Screening and Early Detection of Genitourinary Cancers
Toni Choueiri
1:20-1:35 pm
Q&A
Nicolette Rodriguez
1:35-1:50 pm
Break
1:50-2:05 pm
Multi-Cancer Early Detection Tests – Ready for Prime Time?
Betsy O'Donnell
2:05-2:20 pm
Promoting Equity in screening and Early Detection
Timothy Rebbeck
2:20-2:35 pm
Patient Experience with Multi-Cancer Early Detection testing
Karen Burns White
2:35-2:50 pm
Panel Discussion: Looking to the Future of Early Detection and Interception
Betsy O'Donnell; Timothy Rebbeck; Karen Burns White; Sapna Syngal
2:50-3:05 pm
Faculty
Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.
Elizabeth O’Donnell, MD
Course Director
- Director, Multi-Cancer Early Detection Clinic, Dana-Farber Cancer Institute
- Assistant Professor of Medicine, Harvard Medical School
Sapna Syngal, MD, MPH
Course Director
- Director, Centers for Early Detection and Interception, Solid Tumors, Dana-Farber Cancer Institute
- Director of Research, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute
- Professor of Medicine, Harvard Medical School
Ben Ebert, MD, PhD
President & CEO of Dana Farber
Director of Dana-Farber/Harvard Cancer Center
Richard and Susan Smith Professor of Medicine, Harvard Medical School
Toni Choueiri, MD
Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Professor of Medicine at Harvard Medical School
Colleen Feltmate, MD
Co-Director, Center for Early Detection and Interception, Gynecologic Tumors, Dana-Farber Cancer Institute
Director, Minimally Invasive Surgery in Gynecologic Oncology, Brigham and Women's Hospital
Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology
Irene Ghobrial, MD
Senior Vice President for Experimental Medicine, Dana-Farber Cancer Institute
Director of the Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School
Glenn Hanna, MD
Director, Center for Cancer Therapeutic Innovation (Early Drug Development Program), Dana-Farber Cancer Institute
Director, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Elizabeth Kearns, MS, LGC
Genetic Counselor, Cancer Genetics and Prevention, Dana-Farber Cancer Institute
Nicole Leboeuf, MD, MPH
Vice Chair, Department of Dermatology, Dana-Farber Cancer Center
Director, Cutaneous Oncology, Dana-Farber Cancer Center
Associate Professor of Dermatology, Harvard Medical School
Huma Rana, MD, MPH
Clinical Director, Cancer Genetics and Prevention, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Timothy Rebbeck, PhD
Vincent L. Gregory, Jr. Professor of Cancer Prevention, Harvard TH Chan School of Public Health and Dana-Farber Cancer Institute
Director, Zhu Family Center for Global Cancer Prevention, Harvard TH Chan School of Public Health
Researcher, Division of Population Sciences, Dana Farber Cancer Institute
Nicolette Rodriguez, MD, MPH
Director, Center for Early Detection and Interception, Gastrointestinal Tumors, Dana-Farber Cancer Institute
Instructor in Medicine, Harvard Medical School
Jacob Sands, MD
Associate Chief, Thoracic Oncology, Dana-Farber Cancer Institute
Assistant Professor, Harvard Medical School
Emily Stern Gatof, MD
Oncologist, Breast Oncology and Cancer Genetics and High Risk, Cancer Center at Beth Israel Deaconess Medical Center
Instructor of Clinical Medicine, Harvard Medical School
Lachelle Weeks, MD, PhD
Director, Center for Early Detection and Interception, CHIP, Dana-Farber Cancer Center
Assistant Professor of Medicine, Harvard Medical School
Karen Burns White
Location Information
Venue
All in person sessions will be held at:
Dana Farber Cancer Institute
44 Binney Street
Boston, MA 02115
Learners are also invited to attend virtually.
Hotel Reservations
Hotel Commonwealth
500 Commonwealth Avenue
Boston, MA 02215
www.hotelcommonwealth.com
Sean.Minnihan@hotelcommonwealth.com
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Fee Disclaimer
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment.
Prices include CME credit, electronic syllabus, and refreshments at breaks and breakfast.
At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
| Role | Standard Price |
|---|---|
| Physician (MD/DO) | $500.00 |
| Nurse (RN/APRN) | $250.00 |
| PA | $250.00 |
| Psychologist | $250.00 |
| Resident/Fellow | Free |
| Social Worker | $250.00 |
| Allied Health Professional / Other | $250.00 |
Accreditation
The Harvard Medical School designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School designates this live activity for a maximum of 5.00 ANCC contact hours.
Harvard Medical School has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.